Uncontrolled Hypertension: Clinical Trials

3 trials for Uncontrolled Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 recruiting. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Not yet recruiting 2, Recruiting 1

Follow Uncontrolled Hypertension: new trials by email Literature Review of Uncontrolled Hypertension trials Research Report on Uncontrolled Hypertension

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Food Effect Study of QLS1410 in Healthy Chinese Adults
QLS1410 - Uncontrolled Hypertension
Phase 1Not yet recruitingQilu Pharmaceutical Co., Ltd.122026-01-232026-01-22
A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension
QLS1410 (CYP11B2 inhibitor), placebo - Uncontrolled Hypertension
Phase 1Not yet recruitingQilu Pharmaceutical Co., Ltd.782025-09-012025-09-03
SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
SAL0140, SAL0140 placebo - Uncontrolled Hypertension
Phase 1RecruitingShenzhen Salubris Pharmaceuticals Co., Ltd.822025-06-092025-07-04

Sponsors

Qilu Pharmaceutical Co., Ltd. (2)  ·  Shenzhen Salubris Pharmaceuticals Co., Ltd. (1)

Countries

China (2)

Top investigators

Chongyuan Xu, Ph.D (1)